CVE-2026-50034

An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.

CVSS v3 6.5 MEDIUM

6.5^/10

CVSS v3 : MEDIUM

Vector :

Exploitability : 2.8 / Impact : 3.6

Attack Vector ADJACENT_NETWORK

Attack Complexity LOW

Privileges Required NONE

User Interaction NONE

Confidentiality Impact HIGH

Integrity Impact NONE

Availability Impact NONE

Scope UNCHANGED

References

Link	Resource
https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json
https://www.apollopharmacy.in/contact-us
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01
https://www.cisa.gov/news-events/news/understanding-bluetooth-technology

Configurations

No configuration.

History

25 Oct 2026, 23:10

Type	Values Removed	Values Added
Summary		(es) Un atacante dentro del rango de comunicación BLE puede interceptar pasivamente el tráfico inalámbrico y obtener información sensible relacionada con la salud, incluyendo valores de medición de glucosa.

Information

Published : 2026-06-19 00:16

Updated : 2026-10-25 23:10

NVD link : CVE-2026-50034

Mitre link : CVE-2026-50034

CVE.ORG link : CVE-2026-50034

JSON object : View

Products Affected

No product.

CWE

CWE-319

Cleartext Transmission of Sensitive Information

{"id": "CVE-2026-50034", "cveTags": [], "metrics": {"ssvcV203": [{"source": "134c704f-9b21-4f2e-91b3-4a467353bcc0", "ssvcData": {"id": "CVE-2026-50034", "role": "CISA Coordinator", "options": [{"exploitation": "none"}, {"automatable": "no"}, {"technicalImpact": "partial"}], "version": "2.0.3", "timestamp": "2026-06-22T14:54:09.331370Z"}}], "cvssMetricV31": [{"type": "Secondary", "source": "ics-cert@hq.dhs.gov", "cvssData": {"scope": "UNCHANGED", "version": "3.1", "baseScore": 6.5, "attackVector": "ADJACENT_NETWORK", "baseSeverity": "MEDIUM", "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N", "integrityImpact": "NONE", "userInteraction": "NONE", "attackComplexity": "LOW", "availabilityImpact": "NONE", "privilegesRequired": "NONE", "confidentialityImpact": "HIGH"}, "impactScore": 3.6, "exploitabilityScore": 2.8}], "cvssMetricV40": [{"type": "Secondary", "source": "ics-cert@hq.dhs.gov", "cvssData": {"Safety": "NOT_DEFINED", "version": "4.0", "Recovery": "NOT_DEFINED", "baseScore": 7.1, "Automatable": "NOT_DEFINED", "attackVector": "ADJACENT", "baseSeverity": "HIGH", "valueDensity": "NOT_DEFINED", "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X", "exploitMaturity": "NOT_DEFINED", "providerUrgency": "NOT_DEFINED", "userInteraction": "NONE", "attackComplexity": "LOW", "attackRequirements": "NONE", "privilegesRequired": "NONE", "subIntegrityImpact": "NONE", "vulnIntegrityImpact": "NONE", "integrityRequirement": "NOT_DEFINED", "modifiedAttackVector": "NOT_DEFINED", "subAvailabilityImpact": "NONE", "vulnAvailabilityImpact": "NONE", "availabilityRequirement": "NOT_DEFINED", "modifiedUserInteraction": "NOT_DEFINED", "modifiedAttackComplexity": "NOT_DEFINED", "subConfidentialityImpact": "NONE", "vulnConfidentialityImpact": "HIGH", "confidentialityRequirement": "NOT_DEFINED", "modifiedAttackRequirements": "NOT_DEFINED", "modifiedPrivilegesRequired": "NOT_DEFINED", "modifiedSubIntegrityImpact": "NOT_DEFINED", "modifiedVulnIntegrityImpact": "NOT_DEFINED", "vulnerabilityResponseEffort": "NOT_DEFINED", "modifiedSubAvailabilityImpact": "NOT_DEFINED", "modifiedVulnAvailabilityImpact": "NOT_DEFINED", "modifiedSubConfidentialityImpact": "NOT_DEFINED", "modifiedVulnConfidentialityImpact": "NOT_DEFINED"}}]}, "affected": [{"source": "ics-cert@hq.dhs.gov", "affectedData": [{"vendor": "Apollo Pharmacy", "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)", "versions": [{"status": "affected", "version": "0x0110_v1.1.0"}], "defaultStatus": "unaffected"}]}], "published": "2026-06-19T00:16:47.980", "references": [{"url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json", "source": "ics-cert@hq.dhs.gov"}, {"url": "https://www.apollopharmacy.in/contact-us", "source": "ics-cert@hq.dhs.gov"}, {"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01", "source": "ics-cert@hq.dhs.gov"}, {"url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology", "source": "ics-cert@hq.dhs.gov"}], "vulnStatus": "Awaiting Analysis", "weaknesses": [{"type": "Secondary", "source": "ics-cert@hq.dhs.gov", "description": [{"lang": "en", "value": "CWE-319"}]}], "descriptions": [{"lang": "en", "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values."}, {"lang": "es", "value": "Un atacante dentro del rango de comunicaci\u00f3n BLE puede interceptar pasivamente el tr\u00e1fico inal\u00e1mbrico y obtener informaci\u00f3n sensible relacionada con la salud, incluyendo valores de medici\u00f3n de glucosa."}], "lastModified": "2026-10-25T23:10:00.167", "sourceIdentifier": "ics-cert@hq.dhs.gov"}